Effect of Arjun Manjistha combined and Ingudi in treatment of Melasma

A clinico comparative study of Arjuna Twak (Terminalia arjuna Linn) with Manjistha (Rubia cordifolia Linn) Pralepa and Ingudi (Balanites aegyptiaca Del) Pralepa in the management of Vyanga WSR to Melasma - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085353

Enrollment

Registered

2025-04-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L818- Other specified disorders of pigmentation

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting classical signs and symptoms of Vyanga Patient willing to sign consent form Patient fit for taking this medicine

Exclusion criteria

Exclusion criteria: Melasma due to tuberculosis therapy and malignant cases allergy carcinoma burns herpes eczema psoriasis measles leprosy uncontrolled hormonal disease patients who are reporting allergic history of trial drug

Design outcomes

Primary

Measure	Time frame
change in sign and symptoms of diseaseTimepoint: change in sign and symptoms of disease at 7th week	—

Secondary

Measure	Time frame
assessment of changes in clinical parameter after 15 daysTimepoint: 1st follow up at 15th day 2nd follow up at 30th day after treatment 45th day	—

Countries

India

Contacts

Public ContactDr Sunita D Ram

Govt Auto Dhanwantri Ayurved Medical College

drsunitadram72@gmail.com9424014827

Outcome results